Cargando…
Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
COVID-19, caused by the novel coronavirus SARS-CoV-2, has spread globally and caused serious social and economic problems. The WHO has declared this outbreak a pandemic. Currently, there are no approved vaccines or antiviral drugs that prevent SARS-CoV-2 infection. Drugs already approved for clinica...
Autores principales: | Ku, Keun Bon, Shin, Hye Jin, Kim, Hae Soo, Kim, Bum-Tae, Kim,, Seong-Jun, Kim, Chonsaeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Microbiology and Biotechnology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728307/ https://www.ncbi.nlm.nih.gov/pubmed/33203821 http://dx.doi.org/10.4014/jmb.2009.09009 |
Ejemplares similares
-
A Crucial Role of ACBD3 Required for Coxsackievirus Infection in Animal Model Developed by AAV-Mediated CRISPR Genome Editing Technique
por: Shin, Hye Jin, et al.
Publicado: (2021) -
Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening
por: Kumar, Surendra, et al.
Publicado: (2020) -
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
por: Cannon, Matthew, et al.
Publicado: (2020) -
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
por: Kim, Kevin, et al.
Publicado: (2015) -
Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)